欢迎光临:莱耀标准品网!
 您的位置:对照品 > 标准品 > 英国药典 >
Palbociclib-d4
产品基本信息
产品编号:P139901
产品名称:Palbociclib-d4
产品CAS:
规格含量:10mg
产品价格:面议
联系我们:
产品详细介绍
标准品编号: P139901
名称: Palbociclib-d4
别名: 6-Acetyl-8-cyclopentyl-5-methyl-2-[[5-(1-piperazinyl)-2-pyridinyl]amino]pyrido[2,3-d]pyrimidin-7(8H)-one-d4; 6-Acetyl-8-cyclopentyl-5-methyl-2-[[5-(piperazin-1-yl)pyridin-2-yl]amino]-8H-pyrido[2,3-d]pyrimidin-7-one-d4; Ibrance-d4; PD 0332991-d4; PD 332991-d4; PD 991-d4
参考CAS号: Unlabelled: 571190-30-2
分子式: C₂₄H₂₅D₄N₇O₂
外观: Light Yellow Solid
熔点: >233°C (dec.)
分子量: 451.56
储存: 冰箱
溶解度: DMSO (Slightly, Heated), Methanol (Slightly, Heated)
类别: Standards; Isotopic Labeled Analogues; Pharmaceutical/API Drug Impurities/Metabolites;
应用: Palbociclib-d4 is an isotope labelled compound of Palbociclib (P139900). Palbociclib (P139900) is an experimental drug for the treatment of breast cancer being developed by Pfizer. It is a selective inhibitor of the cyclin-dependent kinases CDK4 and CDK6.
参考文献


2011-2018 信阳莱耀生物科技有限公司 版权所有

中检所标准品,对照品,标准气体
Keywords: 中检所标准品 对照品 标准气体